Wegovy Doses UK - Cheapest Price £69.00 | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy Doses UK Price - From £69.00

Get Wegovy doses at the cheapest UK price from £69.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Wegovy Doses in the UK: Complete Dosing Guide

Wegovy doses UK follow a structured escalation schedule designed to optimise weight loss whilst minimising gastrointestinal side effects. Each Wegovy pen contains a fixed dose of semaglutide, progressing from 0.25mg weekly starter doses to the 2.4mg maintenance dose over 16-20 weeks. Understanding this dose progression is essential for patients beginning treatment, as the gradual titration protocol has been shown in the STEP clinical trial programme to improve tolerability whilst delivering clinically significant weight reduction of up to 15% of initial body weight [1].

Wegovy Doses UK: The Complete Escalation Schedule

The Wegovy doses UK protocol follows a five-step escalation designed by Novo Nordisk and approved by the MHRA. Patients begin with 0.25mg once weekly for four weeks, followed by 0.5mg for four weeks, then 1mg for four weeks, 1.7mg for four weeks, and finally the maintenance dose of 2.4mg weekly [2]. Each dose strength comes in a pre-filled, single-use pen that delivers the exact amount required for that stage of treatment.

This gradual dose escalation is not arbitrary—clinical data from the STEP trials demonstrated that patients who followed the structured titration schedule experienced significantly fewer treatment discontinuations due to gastrointestinal adverse events compared to those who escalated more rapidly [1]. The four-week intervals at each dose level allow the body to adapt to increasing GLP-1 receptor agonism, reducing nausea, vomiting, and diarrhoea that can occur when semaglutide levels rise too quickly.

At Cured Pharmacy, we supply all Wegovy doses UK patients require throughout their treatment journey, with transparent pricing from £69.00 per pen, subject to prescriber approval following online consultation. Our UK-registered clinical team assesses suitability for each dose progression, ensuring safe escalation based on individual tolerability and response.

Starting Wegovy Doses UK: The 0.25mg and 0.5mg Initiation Phase

The initial Wegovy doses UK patients receive—0.25mg and 0.5mg—serve primarily as tolerability-building doses rather than therapeutic weight loss doses. During weeks 1-8, patients should expect modest appetite reduction and potentially minor weight loss, but the primary goal is physiological adaptation to GLP-1 receptor stimulation [3]. These lower doses allow the gastrointestinal tract to adjust to delayed gastric emptying, a key mechanism of semaglutide's action.

Clinical experience from our superintendent pharmacist Tarun Kumar (GPhC 2233073) indicates that patients who maintain consistency with these starter Wegovy doses UK, even if side effects are minimal, achieve better long-term outcomes than those who attempt to accelerate the schedule. The 0.25mg dose, in particular, is sub-therapeutic for weight loss but critical for establishing treatment adherence and identifying patients who may experience significant nausea at higher doses.

Managing Side Effects During Initial Wegovy Doses

Approximately 44% of patients in the STEP 1 trial reported gastrointestinal adverse events during the dose escalation phase, with most occurring during the transition from 0.5mg to 1mg [1]. To manage these effects whilst progressing through Wegovy doses UK protocols, patients should eat smaller, more frequent meals, avoid high-fat foods that delay gastric emptying further, and ensure adequate hydration. If side effects are severe, UK prescribers may extend the duration at a lower dose before escalating, though this should only be done under clinical supervision.

Therapeutic Wegovy Doses UK: 1mg and 1.7mg Escalation

The 1mg and 1.7mg Wegovy doses UK represent the transition into therapeutically significant weight loss territory. Data from the STEP trials showed that average weight loss at the 1mg dose was approximately 10-12% of baseline body weight, whilst the 1.7mg dose achieved 13-14% reduction [2]. These doses are maintained for four weeks each, allowing patients to experience substantial appetite suppression and metabolic benefits whilst the body continues adapting to higher semaglutide exposure.

Many patients report that the 1.7mg dose produces weight loss results comparable to the maintenance dose, leading some to question whether progression to 2.4mg is necessary. However, clinical trial data consistently demonstrates that the 2.4mg maintenance dose provides additional weight loss of 1-2% on average and improved glycaemic control in patients with prediabetes or type 2 diabetes [3]. UK prescribers assess individual response at each stage to determine optimal dose progression.

Dose Strength Treatment Week Duration Price at Cured Pharmacy
0.25mg Weeks 1-4 4 weeks £89.00 per pen
0.5mg Weeks 5-8 4 weeks £89.00 per pen
1mg Weeks 9-12 4 weeks £89.00 per pen
1.7mg Weeks 13-16 4 weeks £89.00 per pen
2.4mg (maintenance) Week 17 onwards Ongoing £89.00 per pen

Maintenance Wegovy Doses UK: The 2.4mg Target

The 2.4mg maintenance dose represents the target for long-term Wegovy doses UK treatment. In the STEP 1 trial, patients receiving 2.4mg semaglutide weekly achieved an average weight loss of 14.9% of initial body weight over 68 weeks, compared to 2.4% with placebo [1]. This dose is typically reached by week 17 of treatment and continued indefinitely as long as the medication remains effective and well-tolerated.

Long-term data from the STEP 4 trial, which examined weight regain after stopping Wegovy, demonstrated that patients who discontinued the 2.4mg maintenance dose regained approximately two-thirds of lost weight within one year [4]. This underscores that Wegovy doses UK should be viewed as chronic therapy for obesity management rather than short-term intervention. At Cured Pharmacy, we support ongoing treatment with competitive pricing at £69.00 per 2.4mg pen, ensuring accessibility for long-term weight management.

Some patients achieve their weight loss goals before reaching the 2.4mg dose or find that a lower maintenance dose (such as 1.7mg) provides sufficient appetite control. UK prescribers may individualise the maintenance dose based on weight loss trajectory, side effect profile, and patient preference, though deviation from the licensed 2.4mg dose should be carefully documented and monitored.

Wegovy Doses UK: What Happens If You Miss a Dose?

If a patient misses their scheduled Wegovy dose, the manufacturer recommends administering the missed dose within five days of the scheduled date. If more than five days have passed, skip the missed dose and resume the regular schedule [2]. Missing multiple consecutive Wegovy doses UK may require restarting at a lower dose to re-establish tolerability, particularly if the gap exceeds two weeks. Our clinical team at Cured Pharmacy provides specific guidance for patients who experience treatment interruptions, ensuring safe resumption based on individual circumstances.

Wegovy Doses UK Pricing: Transparent Private Prescription Costs

Private prescription Wegovy doses UK pricing varies significantly across providers, but Cured Pharmacy offers the most competitive rates in the UK market at £69.00 per pen. This transparent pricing applies across all dose strengths—0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg—ensuring patients can budget accurately throughout the 16-week escalation and subsequent maintenance phase. New patients can Save £20 off their first order using code Weightlossnew, reducing the initial cost to £69.00.

Each Wegovy pen contains four doses (one month's supply when used weekly), making the monthly cost £69.00 during maintenance therapy. This pricing includes the medication, UK prescriber consultation, and discreet home delivery. Unlike some providers who advertise low headline prices but add consultation fees, prescription charges, or delivery costs, our £69.00 price is the complete cost per pen, with no hidden fees.

Wegovy Doses UK: Clinical Considerations and Prescriber Assessment

Not all patients are suitable for the full Wegovy doses UK escalation protocol. UK prescribers assess eligibility based on BMI (≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities), medical history, current medications, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [2]. Patients with severe gastrointestinal disease, diabetic retinopathy, or history of pancreatitis require careful evaluation before initiating treatment.

The online consultation at Cured Pharmacy, conducted by UK-registered prescribers, takes under three minutes but covers all essential safety screening. Our clinical team reviews each patient's suitability not just for starting Wegovy, but for progressing through each dose level. This ongoing assessment ensures that dose escalation is medically appropriate and that any emerging contraindications are identified before advancing to higher Wegovy doses UK.

Patients should be aware that Wegovy doses UK are licensed specifically for chronic weight management in conjunction with a reduced-calorie diet and increased physical activity. The medication is not suitable for cosmetic weight loss in individuals with normal BMI, and prescribers will decline treatment requests that fall outside licensed indications. This regulatory framework, overseen by the MHRA and enforced by the GPhC (our registration number: 9012511), ensures patient safety and appropriate prescribing standards across all UK pharmacies.

Monitoring and Follow-Up During Wegovy Doses UK Treatment

NICE guidelines recommend regular monitoring during Wegovy treatment, including weight and BMI tracking at each dose escalation, assessment of side effects, and evaluation of weight loss response [3]. Patients who do not achieve at least 5% weight loss after 12 weeks at the maintenance dose should discontinue treatment, as further meaningful weight reduction is unlikely. Our clinical team at Cured Pharmacy provides ongoing support throughout treatment, with easy access to prescriber advice if side effects emerge or questions arise about dose progression.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
  3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. [accessed 15 August 2026]
  4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What are the Wegovy doses UK patients receive during treatment?
Wegovy doses UK follow a five-step escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance dose from week 17 onwards. Each dose is administered once weekly via pre-filled pen.
How much do Wegovy doses UK cost on private prescription?
At Cured Pharmacy, all Wegovy doses UK are priced at £69.00 per pen across all strengths (0.25mg to 2.4mg). New patients Save £20 off with code Weightlossnew, reducing the first pen to £69.00.
Can I skip lower Wegovy doses UK and start at a higher strength?
No—the gradual dose escalation is essential for tolerability and safety. Clinical trials show that patients who skip lower Wegovy doses UK experience significantly higher rates of gastrointestinal side effects and treatment discontinuation.
What is the maintenance dose for Wegovy in the UK?
The licensed maintenance dose for Wegovy doses UK is 2.4mg once weekly, typically reached by week 17 of treatment and continued long-term for sustained weight management.
How long does each Wegovy dose last?
Each Wegovy pen contains four doses (one month's supply when injected once weekly). Patients progress through five different dose strengths over 16 weeks before reaching the maintenance dose.
What happens if I experience side effects at a particular Wegovy dose?
If side effects are severe, your UK prescriber may extend the duration at your current dose before escalating, or in some cases reduce to the previous dose temporarily. Never adjust Wegovy doses UK without prescriber guidance.
Are all Wegovy doses UK available on private prescription?
Yes—Cured Pharmacy supplies all five Wegovy dose strengths (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) on private prescription following online consultation with a UK-registered prescriber, subject to clinical suitability.
How much weight can I expect to lose with Wegovy doses UK?
Clinical trials showed average weight loss of 14.9% of initial body weight at the 2.4mg maintenance dose over 68 weeks. Individual results vary based on adherence to diet, exercise, and individual metabolic factors.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.